19 results
10-K
2023 FY
EX-4.4
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, par value $0.0001 per share.
Corporate Governance
We are a corporation organized under the laws of the state of Florida and are governed
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
will increase its costs and expenses.
In addition, changing laws, regulations and standards relating to corporate governance and public disclosure … Inspections
Not applicable.
PART III
Item 10. Directors, Executive Officers and Corporate Governance.
March 2024 Changes to Our Management and Board
8-K
MIRA
Mira Pharmaceuticals Inc
13 Mar 24
Departure of Directors or Certain Officers
4:30pm
. In due course, the new Board will designate the new members of the Audit, Compensation and Nominating and Corporate Governance Committees
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
and standards relating to corporate governance and public disclosure are creating uncertainty for public companies, increasing legal and financial compliance … . She also brings deep corporate governance experience through her work with corporate boards, including audit and finance committees. Since May 2022, Ms
424B1
eqfju pifl
4 Aug 23
Prospectus with pricing info
12:59pm
S-1
EX-99.2
io5ara9hw
29 Jun 23
IPO registration
4:39pm
S-1
EX-99.4
n23mfl3emmazbc2 81l6
29 Jun 23
IPO registration
4:39pm
S-1
enracur 57run6lmz
29 Jun 23
IPO registration
4:39pm
DRS/A
EX-99.2
0yuis1eouppsx
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
003aiij6ja0v
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
gcnb0qo2h
2 May 23
Draft registration statement (amended)
12:00am
DRS
ybg0vd02quovvii5lg6
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next